11 Recruiting Advanced Non-Small Cell Lung Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Advanced Non-Small Cell Lung Cancer
Top Recruiting Advanced Non-Small Cell Lung Cancer Studies
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
📍 The Oncology Institute of Hope and Innovation — Los Angeles, California
View Study & Checklist ➔Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
📍 Regeneron Research Facility — Tarrytown, New York
View Study & Checklist ➔A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
📍 Arizona Clinical Research Center — Tucson, Arizona
View Study & Checklist ➔The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔Study With Various Immunotherapy Treatments in Participants With Lung Cancer
📍 University of Alabama at Birmingham (UAB) — Birmingham, Alabama
View Study & Checklist ➔Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
📍 Pioneer Research Center — Bullhead City, Arizona
View Study & Checklist ➔T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
📍 Local Institution - 007-556-A — Goodyear, Arizona
View Study & Checklist ➔First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
📍 Banner MD Anderson Cancer Center at Banner Gateway Medical Center — Gilbert, Arizona
View Study & Checklist ➔Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔